What is Belviq?
Lorcaserin, marketed under the brand name Belviq, is a weight-loss pill developed by Arena Pharmaceuticals and manufactured by Eisai Inc. The drug works to control appetite by activating brain receptors for serotonin, a neurotransmitter that triggers feelings of satiety and satisfaction. Belviq was approved by the FDA on June 27, 2012.
Belviq Cancer Recall
Eisai Inc. withdrew Belviq from the U.S. market on Feb. 13, 2020, at the request of federal health regulators who said the drug had been linked to an increased risk for cancer. A recently completed FDA analysis of a safety study indicated that 7.7% of participants who took Belviq were diagnosed with cancer, compared to 7.1% who developed cancer after taking a placebo. Cancers reported included pancreatic cancer, colorectal cancer and lung cancer, FDA said.
Belviq Side Effects
Serious side effects of Belviq may include:
- Lung Cancer
- Colorectal Cancer
- Colon Cancer
- Pancreatic Cancer
- Breast Cancer
- Cardiovascular Events
- Heart Attack
- Stroke
- Hypertension
- Heart Valve Damage
- Serotonin Syndrome
- And more
Weight-Loss Drug May Increase Cancer Risk: ABC Action News Video
Do I Have a Belviq Class Action Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Belviq lawsuits. We are handling individual litigation nationwide and currently accepting new cancer cases in all 50 states.
Again, if you were diagnosed with cancer after taking Belviq, you should contact the law offices of Schmidt & Clark, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.